Diabetes Mellitus, Type 2: all 9,590 studies

Page 23 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.

• A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin TreatmentCompletedNCT01894568Phase 3Results posted
• Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes MellitusCompletedNCT01892020Phase 4Results posted
• Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT01889667Phase 2Results posted
• Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 DiabetesCompletedNCT01885208Phase 3Results posted
• Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart DiseaseCompletedNCT01884545Not applicableResults posted
• Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 DiabetesCompletedNCT01882907Phase 4Results posted
• A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 DiabetesCompletedNCT01880736Phase 3Results posted
• Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic NephropathyCompletedNCT01874431Phase 2Results posted
• Vildagliptin/Metformin in T2DM Patients Starting Basal InsulinCompletedNCT01871558Phase 3Results posted
• A Study of LY3025876 in Participants With DiabetesCompletedNCT01870297Phase 1Results posted
• A Study of LY2405319 in Participants With Type 2 DiabetesCompletedNCT01869959Phase 1Results posted
• Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes MellitusCompletedNCT01868646Phase 4Results posted
• A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)CompletedNCT01868542Phase 4Results posted
• Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy ControlsCompletedNCT01867307Phase 2Results posted
• A Study of Multiple Doses of LY2922470 in Participants With DiabetesCompletedNCT01867216Phase 1Results posted
• Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 DiabetesCompletedNCT01864174Phase 4Results posted
• A Study to Evaluate the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)TerminatedNCT01863667Phase 3Results posted
• The Diabetes Medication Choice Cards Trial in GreeceCompletedNCT01861756Not applicableResults posted
• PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus PatientsCompletedNCT01856595Phase 1Results posted
• Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 DiabetesCompletedNCT01850615Phase 3Results posted
• A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT01849289Phase 3Results posted
• A Study in CKD Patients With Type 2 Diabetes Mellitus and AlbuminuriaCompletedNCT01847092Phase 2Results posted
• Sitagliptin Therapy in Hospitalized Patients With Type 2 DiabetesCompletedNCT01845831Phase 4Results posted
• OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck.CompletedNCT01842620Phase 4Results posted
• Amlexanox for Type 2 Diabetes and ObesityTerminatedNCT01842282Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)CompletedNCT01841697Phase 3Results posted
• Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in PregnancyCompletedNCT01837680Not applicableResults posted
• Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 DiabetesTerminatedNCT01834274Phase 3Results posted
• Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 DiabetesTerminatedNCT01829477Phase 3Results posted
• Linagliptin Among Filipino Patients With Type 2 Diabetes MellitusTerminatedNCT01826370Results posted
• Ticagrelor Versus Clopidogrel in Type 2 Diabetic PatientsCompletedNCT01823510Phase 4Results posted
• Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 DiabetesCompletedNCT01822548Phase 3Results posted
• Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 WeeksCompletedNCT01819272Phase 2Results posted
• Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 DiabetesCompletedNCT01819129Phase 3Results posted
• An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II DiabetesTerminatedNCT01817777Phase 4Results posted
• Computer Automation for Diagnosis and Management of Childhood Type 2 DiabetesCompletedNCT01814787Not applicableResults posted
• A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)CompletedNCT01814748Phase 3Results posted
• A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice DailyCompletedNCT01814137Phase 3Results posted
• Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin MonotherapyCompletedNCT01811485Phase 3Results posted
• A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and ExerciseCompletedNCT01809327Phase 3Results posted
• Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DMCompletedNCT01804842Phase 1/2Results posted
• Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic PatientsCompletedNCT01798706Phase 3Results posted
• Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 DiabetesCompletedNCT01798264Phase 1Results posted
• Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah PopulationCompletedNCT01798225Phase 4Results posted
• A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 DiabetesCompletedNCT01794143Phase 3Results posted
• Type 2 Diabetes and Exercise Function in Single Leg ExercisesCompletedNCT01793909Not applicableResults posted
• A 6-Week Study Of PF-05175157 In Type 2 Diabetes MellitusTerminatedNCT01792635Phase 2Results posted
• MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptinCompletedNCT01792518Phase 3Results posted
• A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 DiabetesCompletedNCT01790438Phase 3Results posted
• Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes MellitusCompletedNCT01786707Phase 1/2Results posted
• Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PADCompletedNCT01785524Phase 2Results posted
• Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 DiabetesCompletedNCT01778049Phase 3Results posted
• A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01777282Phase 3Results posted
• Study of Human Regular U-500 Insulin in Adult Participants With Type 2 DiabetesCompletedNCT01774968Phase 4Results posted
• Comparison of Insulin Mix25 Versus Mix50CompletedNCT01773473Phase 4Results posted
• The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic PatientsCompletedNCT01770483Phase 4Results posted
• Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)CompletedNCT01769378Phase 3Results posted
• Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic PatientsCompletedNCT01768559Phase 3Results posted
• A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031)CompletedNCT01767688Phase 1Results posted
• Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by MetforminCompletedNCT01766778Phase 4Results posted
• Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft SurgeryTerminatedNCT01765270Phase 4Results posted
• Beta Cell Restoration Through Fat MitigationCompletedNCT01763346Not applicableResults posted
• Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in HumansCompletedNCT01762046Phase 1Results posted
• A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)CompletedNCT01760447Phase 3Results posted
• A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)CompletedNCT01755156Phase 3Results posted
• Lipid Biomarkers for Diabetic Heart DiseaseCompletedNCT01752842Not applicableResults posted
• A Single Dose Study of LY2605541 in Participants With Liver ImpairmentCompletedNCT01751399Phase 1Results posted
• A Study of LY2922083 in Healthy Participants and Participants With DiabetesCompletedNCT01748552Phase 1Results posted
• A Study of LY2922470 in Healthy Participants and Participants With DiabetesCompletedNCT01746017Phase 1Results posted
• Vitamin D for Established Type 2 Diabetes (DDM2)CompletedNCT01736865Phase 2/3Results posted
• Computerized Cognitive Training for Diabetic Elderly VeteransCompletedNCT01736124Phase 4Results posted
• Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01734785Phase 3Results posted
• A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)CompletedNCT01733758Phase 3Results posted
• Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular EventsCompletedNCT01730534Phase 3Results posted
• Effects of Metformin on Hepatic FFA MetabolismCompletedNCT01729156Phase 4Results posted
• Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are ObeseTerminatedNCT01728116Not applicableResults posted
• Effects of Obesity Treatments on Food Preferences and MetabolismCompletedNCT01724060Results posted
• Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 DiabetesCompletedNCT01720446Phase 3Results posted
• Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 DiabetesCompletedNCT01719003Phase 3Results posted
• A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)CompletedNCT01717313Phase 3Results posted
• A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime InsulinCompletedNCT01713530Phase 3Results posted
• A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt NephropathyCompletedNCT01712061Phase 2Results posted
• A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)CompletedNCT01709305Phase 4Results posted
• Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 PatientsCompletedNCT01708902Phase 3Results posted
• A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes MellitusCompletedNCT01707147Results posted
• Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)CompletedNCT01704261Phase 3Results posted
• Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)CompletedNCT01703286Phase 1Results posted
• Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)CompletedNCT01703221Phase 3Results posted
• A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018)TerminatedNCT01703208Phase 3Results posted
• A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)CompletedNCT01702298Phase 3Results posted
• A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)CompletedNCT01698775Phase 3Results posted
• Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and TitrationCompletedNCT01698528Not applicableResults posted
• Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)CompletedNCT01697592Phase 3Results posted
• Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart FunctionCompletedNCT01686932Phase 4Results posted
• T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone InsulinCompletedNCT01686828Phase 1/2Results posted
• A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)CompletedNCT01682759Phase 3Results posted
• Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin GlargineCompletedNCT01680341Phase 3Results posted
• Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume CombinationsCompletedNCT01680328Phase 1Results posted
• A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)TerminatedNCT01678820Phase 3Results posted
• Study of Raisins Versus Alternative Snacks in Patients With Type 2 Diabetes MellitusCompletedNCT01677936Phase 4Results posted

← Diabetes Mellitus, Type 2 overview